JP3101690B2
(ja)
|
1987-03-18 |
2000-10-23 |
エス・ビィ・2・インコーポレイテッド |
変性抗体の、または変性抗体に関する改良
|
ATE197053T1
(de)
|
1988-05-27 |
2000-11-15 |
Applied Research Systems |
Humaner rezeptor fc(gamma)riii
|
DK0463151T3
(da)
|
1990-01-12 |
1996-07-01 |
Cell Genesys Inc |
Frembringelse af xenogene antistoffer
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5258359A
(en)
|
1991-08-02 |
1993-11-02 |
Monsanto Company |
Glyphosant-containing herbicidal compositions comprising acetylenic diol rainfastness enhancing agents
|
EP0663952A4
(fr)
|
1992-09-11 |
1997-06-11 |
Univ California |
Animaux transgeniques possedant des genes de transduction lymphocytaire cibles.
|
US5877396A
(en)
|
1993-04-23 |
1999-03-02 |
Sloan Kettering Institute For Cancer Research |
Mice mutant for functional Fc receptors and method of treating autoimmune diseases
|
US6111166A
(en)
|
1994-09-19 |
2000-08-29 |
Medarex, Incorporated |
Transgenic mice expressing human Fcα and β receptors
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
EP0822830B1
(fr)
*
|
1995-04-27 |
2008-04-02 |
Amgen Fremont Inc. |
Anticorps anti-IL-8 dérivés de xenosouris immunisées
|
ES2301183T3
(es)
|
1996-12-03 |
2008-06-16 |
Amgen Fremont Inc. |
Anticuerpo completamente humano que se une al receptor del egfr.
|
US6528624B1
(en)
|
1998-04-02 |
2003-03-04 |
Genentech, Inc. |
Polypeptide variants
|
GB9823930D0
(en)
|
1998-11-03 |
1998-12-30 |
Babraham Inst |
Murine expression of human ig\ locus
|
US7183387B1
(en)
|
1999-01-15 |
2007-02-27 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
US6676927B1
(en)
|
1999-01-20 |
2004-01-13 |
The Rockefeller University |
Animal model and methods for its use in the selection of cytotoxic antibodies
|
FR2807767B1
(fr)
|
2000-04-12 |
2005-01-14 |
Lab Francais Du Fractionnement |
Anticorps monoclonaux anti-d
|
JP3597140B2
(ja)
*
|
2000-05-18 |
2004-12-02 |
日本たばこ産業株式会社 |
副刺激伝達分子ailimに対するヒトモノクローナル抗体及びその医薬用途
|
US7413031B2
(en)
|
2000-07-18 |
2008-08-19 |
The Charles Machine Works, Inc. |
Apparatus and method for maintaining control of a drilling machine
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
US6586251B2
(en)
|
2000-10-31 |
2003-07-01 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
US7105348B2
(en)
|
2000-10-31 |
2006-09-12 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
US6992234B2
(en)
|
2000-11-06 |
2006-01-31 |
The Jackson Laboratory |
FcRn-based therapeutics for the treatment of auto-immune disorders
|
EP1362093B1
(fr)
|
2001-02-20 |
2010-11-17 |
University Of Georgia Research Foundation, Inc. |
Production rapide d'anticorps monoclonaux
|
FR2822161B1
(fr)
|
2001-03-15 |
2003-09-19 |
Genoway |
Cellule et animal transgenique modelisant les reponses humaines allergiques mediees par les ige, et leurs utilisations
|
JP4653915B2
(ja)
|
2001-10-29 |
2011-03-16 |
独立行政法人科学技術振興機構 |
全身性エリテマトーデスモデル非ヒト動物
|
US7737260B2
(en)
*
|
2003-11-13 |
2010-06-15 |
Hanmi Pharm. Co., Ltd |
Protein complex using an immunoglobulin fragment and method for the preparation thereof
|
US20090042291A1
(en)
|
2002-03-01 |
2009-02-12 |
Xencor, Inc. |
Optimized Fc variants
|
US8093357B2
(en)
|
2002-03-01 |
2012-01-10 |
Xencor, Inc. |
Optimized Fc variants and methods for their generation
|
US7317091B2
(en)
|
2002-03-01 |
2008-01-08 |
Xencor, Inc. |
Optimized Fc variants
|
US20040132101A1
(en)
|
2002-09-27 |
2004-07-08 |
Xencor |
Optimized Fc variants and methods for their generation
|
CA2488775C
(fr)
|
2002-06-07 |
2011-04-12 |
Arthron Limited |
Modele animal transgenique de fcyriia pour affection auto-immune
|
JP2004147535A
(ja)
|
2002-10-29 |
2004-05-27 |
Japan Science & Technology Agency |
ギラン・バレー症候群及び/又はフィッシャー症候群発症モデル非ヒト動物
|
KR20050084318A
(ko)
|
2002-12-16 |
2005-08-26 |
제넨테크, 인크. |
인간 cd20을 발현하는 트랜스제닉 마우스
|
US8388955B2
(en)
|
2003-03-03 |
2013-03-05 |
Xencor, Inc. |
Fc variants
|
US20090010920A1
(en)
|
2003-03-03 |
2009-01-08 |
Xencor, Inc. |
Fc Variants Having Decreased Affinity for FcyRIIb
|
US20100069614A1
(en)
|
2008-06-27 |
2010-03-18 |
Merus B.V. |
Antibody producing non-human mammals
|
FR2858235B1
(fr)
|
2003-07-31 |
2006-02-17 |
Lab Francais Du Fractionnement |
Utilisation d'anticorps optimises en adcc pour traiter les patients faibles repondeurs
|
US8218805B2
(en)
|
2003-10-11 |
2012-07-10 |
Charles Hornback |
Wireless speaker system for use with ceiling fans
|
WO2005063815A2
(fr)
|
2003-11-12 |
2005-07-14 |
Biogen Idec Ma Inc. |
Variants de polypeptides de liaison au recepteur fc$g(g) et procede apparentes
|
JP2008507257A
(ja)
*
|
2004-03-19 |
2008-03-13 |
アムゲン・インコーポレーテッド |
V遺伝子の操作を介したヒト抗ヒト抗体の危険性の低減
|
EP2295588B1
(fr)
|
2004-05-27 |
2018-03-07 |
The Trustees Of The University Of Pennsylvania |
Nouvel antigène artificiel présentant des cellules et utilisations associées
|
CA2583750C
(fr)
|
2004-10-19 |
2015-11-24 |
Regeneron Pharmaceuticals, Inc. |
Methode de production d'un animal homozygote pour une modification genetique
|
US7632497B2
(en)
|
2004-11-10 |
2009-12-15 |
Macrogenics, Inc. |
Engineering Fc Antibody regions to confer effector function
|
WO2007001457A2
(fr)
|
2004-11-12 |
2007-01-04 |
Xencor, Inc. |
Anticorps fonctionnellement lies a des facteurs chimiotactiques selectionnes
|
US20060275282A1
(en)
|
2005-01-12 |
2006-12-07 |
Xencor, Inc. |
Antibodies and Fc fusion proteins with altered immunogenicity
|
WO2007022520A2
(fr)
|
2005-08-19 |
2007-02-22 |
Cerus Corporation |
Renfort induit par anticorps de reponse immune
|
SG170110A1
(en)
|
2006-03-10 |
2011-04-29 |
Macrogenics Inc |
Identification and engineering of antibodies with variant heavy chains and methods of using same
|
JP5514539B2
(ja)
|
2006-03-31 |
2014-06-04 |
メダレックス・リミテッド・ライアビリティ・カンパニー |
ヒト抗体の調製に用いるためのキメラ抗体を発現するトランスジェニック動物
|
US20080003225A1
(en)
|
2006-06-29 |
2008-01-03 |
Henri Vie |
Method for enhancing the antibody-dependent cellular cytotoxicity (ADCC) and uses of T cells expressing CD16 receptors
|
WO2008028068A2
(fr)
|
2006-08-30 |
2008-03-06 |
Genentech, Inc. |
POLYPEPTIDES FCεR1α DE PRIMATES NON HUMAINS
|
SG174053A1
(en)
|
2006-09-01 |
2011-09-29 |
Therapeutic Human Polyclonals Inc |
Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals
|
US20090053210A1
(en)
|
2006-09-01 |
2009-02-26 |
Roland Buelow |
Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals
|
US8042033B2
(en)
|
2006-11-29 |
2011-10-18 |
Lg Electronics Inc. |
Protection of access information in wireless communications
|
ATE504647T1
(de)
|
2007-01-30 |
2011-04-15 |
Forerunner Pharma Res Co Ltd |
Chimärer fc gamma rezeptor und verfahren zur bestimmung von adcc-aktivität unter verwendung des rezeptors
|
US7816082B2
(en)
|
2007-03-06 |
2010-10-19 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Methods of identifying pancreatic cancer cells
|
ES2672769T3
(es)
*
|
2007-08-29 |
2018-06-18 |
Sanofi |
Anticuerpos anti-CXCR5 humanizados, derivados de los mismos y sus usos
|
EP2245155A4
(fr)
|
2007-12-10 |
2011-05-25 |
Aliva Biopharmaceuticals Inc |
Procédés pour le remplacement séquentiel d'une zone ciblée par recombinaison homologue
|
US8658766B2
(en)
|
2008-06-27 |
2014-02-25 |
Zymogenetics, Inc. |
Soluble hybrid Fcγ receptors and related methods
|
WO2010010549A2
(fr)
|
2008-07-23 |
2010-01-28 |
Rappaport Family Institute For Research In The Medical Sciences |
Procédé de modification de populations de cellules b périphériques et utilisations associées
|
GB0909906D0
(en)
*
|
2009-06-09 |
2009-07-22 |
Affitech As |
Antibodies
|
US20120204278A1
(en)
|
2009-07-08 |
2012-08-09 |
Kymab Limited |
Animal models and therapeutic molecules
|
US9445581B2
(en)
*
|
2012-03-28 |
2016-09-20 |
Kymab Limited |
Animal models and therapeutic molecules
|
CN102741404B
(zh)
|
2009-11-17 |
2017-03-08 |
Sab有限责任公司 |
人类人工染色体载体
|
HUE030208T2
(en)
*
|
2009-12-10 |
2017-04-28 |
Regeneron Pharma |
Heavy-chain antibody-producing mice
|
KR102178064B1
(ko)
|
2009-12-21 |
2020-11-12 |
리제너론 파마슈티칼스 인코포레이티드 |
인간화된 FcγR 마우스
|
US8883496B2
(en)
|
2009-12-21 |
2014-11-11 |
Regeneron Phamaceuticals, Inc. |
Humanized FcgR mice
|
US20130185821A1
(en)
|
2010-02-08 |
2013-07-18 |
Regeneron Pharmaceuticals, Inc. |
Common Light Chain Mouse
|
US9796788B2
(en)
|
2010-02-08 |
2017-10-24 |
Regeneron Pharmaceuticals, Inc. |
Mice expressing a limited immunoglobulin light chain repertoire
|
US20130108623A1
(en)
|
2010-03-29 |
2013-05-02 |
Zymeworks Inc |
Antibodies with Enhanced or Suppressed Effector Function
|
TWI667346B
(zh)
*
|
2010-03-30 |
2019-08-01 |
中外製藥股份有限公司 |
促進抗原消失之具有經修飾的FcRn親和力之抗體
|
CN103228130B
(zh)
|
2010-06-17 |
2016-03-16 |
科马布有限公司 |
动物模型及治疗分子
|
CN103068993B
(zh)
|
2010-06-22 |
2016-01-06 |
瑞泽恩制药公司 |
杂交轻链小鼠
|
ES2612459T3
(es)
|
2010-08-02 |
2017-05-17 |
Regeneron Pharmaceuticals, Inc. |
Ratones que producen proteínas de unión que comprenden dominios VL
|
SG10201913160QA
(en)
|
2011-02-25 |
2020-03-30 |
Regeneron Pharma |
Adam6 mice
|
JP5893258B2
(ja)
|
2011-03-31 |
2016-03-23 |
フェリカネットワークス株式会社 |
情報処理装置および方法、並びにプログラム
|
HUE057680T2
(hu)
|
2011-10-17 |
2022-06-28 |
Regeneron Pharma |
Korlátozott immunglobulin-nehézlánccal rendelkezõ egerek
|
EP4052572A1
(fr)
|
2011-10-28 |
2022-09-07 |
Regeneron Pharmaceuticals, Inc. |
Souris transgéniques exprimant des molécules chimeriques du complexe majeur d'histocompatibilité (mhc) ii
|
SG10202100485XA
(en)
|
2011-10-28 |
2021-02-25 |
Regeneron Pharma |
Humanized il-6 and il-6 receptor
|
US9591835B2
(en)
|
2011-10-28 |
2017-03-14 |
Regeneron Pharmaceuticals, Inc. |
Genetically modified major histocompatibility complex animals
|
ES2651517T3
(es)
|
2011-10-28 |
2018-01-26 |
Regeneron Pharmaceuticals, Inc. |
Ratones con complejo mayor de histocompatibilidad modificado genéticamente
|
KR102052774B1
(ko)
|
2011-11-04 |
2019-12-04 |
자임워크스 인코포레이티드 |
Fc 도메인 내의 돌연변이를 갖는 안정한 이종이합체 항체 설계
|
WO2013138712A1
(fr)
|
2012-03-16 |
2013-09-19 |
Regeneron Pharmaceuticals, Inc. |
ANIMAUX NON HUMAINS EXPRIMANT DES SÉQUENCES D'IMMUNOGLOBULINE SENSIBLES AU pH
|
US20140013456A1
(en)
|
2012-03-16 |
2014-01-09 |
Regeneron Pharmaceuticals, Inc. |
Histidine Engineered Light Chain Antibodies and Genetically Modified Non-Human Animals for Generating the Same
|
EP2825035A1
(fr)
|
2012-03-16 |
2015-01-21 |
Regeneron Pharmaceuticals, Inc. |
Souris produisant des protéines de liaison à l'antigène ayant des caractéristiques de liaison dépendant du ph
|
KR102228296B1
(ko)
|
2012-03-16 |
2021-03-17 |
리제너론 파마슈티칼스 인코포레이티드 |
히스티딘 공학처리된 경쇄 항체 및 그것을 생성하기 위한 유전자 변형된 비-사람 동물
|
GB2502127A
(en)
*
|
2012-05-17 |
2013-11-20 |
Kymab Ltd |
Multivalent antibodies and in vivo methods for their production
|
US10251377B2
(en)
|
2012-03-28 |
2019-04-09 |
Kymab Limited |
Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies
|
JP2015512635A
(ja)
|
2012-03-28 |
2015-04-30 |
カイマブ・リミテッド |
クラススイッチした完全ヒト抗体の発現のためのトランスジェニック非−ヒト脊椎動物
|
JP5920830B2
(ja)
|
2012-09-28 |
2016-05-18 |
シスメックス株式会社 |
試料調製装置および細胞分析装置
|
ES2748662T3
(es)
|
2012-11-05 |
2020-03-17 |
Institute For Res In Biomedicine Irb |
Roedores inmunodeficientes modificados genéticamente y métodos de uso de los mismos
|
BR112015019350A2
(pt)
*
|
2013-02-20 |
2017-08-22 |
Regeneron Pharma |
Animal não humano, locus de imunoglobulina, e, métodos de fabricação de um animal não humano, para a obtenção de uma sequência de ácido nucleico e de fabricação de uma proteína de ligação ao antígeno
|
EP2958938B1
(fr)
|
2013-02-20 |
2019-04-17 |
Regeneron Pharmaceuticals, Inc. |
Souris exprimant des corecepteurs humanisées des lymphocytes t
|
US20150342163A1
(en)
|
2013-02-22 |
2015-12-03 |
Regeneron Pharmaceuticals, Inc. |
Genetically modified major histocompatibility complex mice
|
CA2900824A1
(fr)
|
2013-02-22 |
2014-08-28 |
Regeneron Pharmaceuticals, Inc. |
Souris exprimant un complexe majeur d'histocompatibilite
|
PL3456831T3
(pl)
|
2013-04-16 |
2021-12-06 |
Regeneron Pharmaceuticals, Inc. |
Ukierunkowana modyfikacja genomu szczura
|
EP2837637A1
(fr)
*
|
2013-08-16 |
2015-02-18 |
SuppreMol GmbH |
Nouveaux anticorps de type IgG anti-FcyRIIB
|
SI3175706T1
(sl)
|
2013-09-23 |
2019-03-29 |
Regeneron Pharmaceuticals, Inc. |
Nehumane živali s humaniziranim genom signal-regulatornega proteina
|
WO2015077071A1
(fr)
|
2013-11-19 |
2015-05-28 |
Regeneron Pharmaceuticals, Inc. |
Animaux non humains ayant un gène de facteur activant les cellules b humanisé
|
RU2685914C1
(ru)
|
2013-12-11 |
2019-04-23 |
Регенерон Фармасьютикалс, Инк. |
Способы и композиции для направленной модификации генома
|
JP6267986B2
(ja)
*
|
2014-02-13 |
2018-01-24 |
株式会社特殊免疫研究所 |
ヒトの特定分子と結合する分子標的物質のinvivo評価法
|
PL3129400T3
(pl)
*
|
2014-04-08 |
2020-09-07 |
Regeneron Pharmaceuticals, Inc. |
Zwierzęta inne niż człowiek mające humanizowane receptory fc-gamma
|
NO2785538T3
(fr)
|
2014-05-07 |
2018-08-04 |
|
|
FI3841877T3
(fi)
|
2014-05-19 |
2023-12-01 |
Regeneron Pharma |
Ihmisen epo:a ilmentäviä geneettisesti muunneltuja hiiriä
|
KR102374379B1
(ko)
|
2014-06-06 |
2022-03-17 |
리제너론 파마슈티칼스 인코포레이티드 |
표적화된 좌를 변형시키는 방법 및 조성물
|
PT3157956T
(pt)
|
2014-06-19 |
2020-04-09 |
Regeneron Pharma |
Animais não humanos com um gene 1 de morte programada humanizada em células
|
HUE049405T2
(hu)
|
2014-06-23 |
2020-09-28 |
Regeneron Pharma |
Nukleáz-közvetített DNS-összeállítás
|
RS61080B1
(sr)
|
2014-11-24 |
2020-12-31 |
Regeneron Pharma |
Ne-humane životinje koje eksprimiraju humanizovani cd3 kompleks
|
HUE043132T2
(hu)
*
|
2014-12-05 |
2019-07-29 |
Regeneron Pharma |
Nem-humán állatok, amelyek egy humanizált differenciáció klaszter 47 gént tartalmazzák
|
MX2017007636A
(es)
|
2014-12-09 |
2018-03-28 |
Regeneron Pharma |
Animales no humanos que tienen un gen del grupo de diferenciacion 274 humanizado.
|
CN113349159B
(zh)
|
2015-04-06 |
2022-11-11 |
瑞泽恩制药公司 |
非人动物中的人源化t细胞介导的免疫应答
|
EP3289869B1
(fr)
*
|
2015-04-30 |
2020-10-14 |
Institute Of Immunology Co., Ltd. |
Animal non-humain transgénique exprimant des molécules spécifiques à un être humain et famille de récepteurs fc gamma humains
|
CA2986721A1
(fr)
*
|
2015-05-22 |
2016-12-01 |
Champions Oncology, Inc. |
Souris humanisees et leurs utilisations
|
CN107709550A
(zh)
*
|
2015-06-18 |
2018-02-16 |
转基因股份有限公司 |
脏器人源化小鼠
|
US11612149B2
(en)
*
|
2015-07-10 |
2023-03-28 |
Chugai Seiyaku Kabushiki Kaisha |
Non-human animal having human CD3 gene substituted for endogenous CD3 gene
|
RU2745403C2
(ru)
|
2015-11-20 |
2021-03-24 |
Регенерон Фармасьютикалз, Инк. |
Животные, отличные от человека, имеющие гуманизированный ген активации лимфоцитов-3
|
EP4368637A2
(fr)
|
2016-05-20 |
2024-05-15 |
Regeneron Pharmaceuticals, Inc. |
Procédés pour briser la tolérance immunologique à l'aide de multiples arn de guidage
|
SG11201903344XA
(en)
|
2016-11-04 |
2019-05-30 |
Regeneron Pharma |
Non-human animals having an engineered immunoglobulin lambda light chain locus
|
EP3644722A1
(fr)
|
2017-06-27 |
2020-05-06 |
Regeneron Pharmaceuticals, Inc. |
Animaux non humains comprenant un locus asgr1
|
EP3585164B1
(fr)
|
2017-11-30 |
2023-12-27 |
Regeneron Pharmaceuticals, Inc. |
Rats comprenant un locus trkb humanisé
|
MA52177A
(fr)
|
2018-03-26 |
2021-02-17 |
Regeneron Pharma |
Rongeurs humanisés pour tester des agents thérapeutiques
|